pubmed-article:18374401 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C0034786 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C0205341 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C1414313 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
pubmed-article:18374401 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:18374401 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18374401 | pubmed:dateCreated | 2008-5-5 | lld:pubmed |
pubmed-article:18374401 | pubmed:abstractText | Length of a polymorphic cytosine-adenine-guanine (CAG) repeat in the androgen receptor (AR) may inversely correlate with AR activity. We have identified an association between short AR allelotypes and decreased survival in women with epithelial ovarian cancer. We hypothesize short AR allelotypes promote aggressive ovarian cancer phenotype through modulation of epidermal growth factor receptor (EGFR) signaling. | lld:pubmed |
pubmed-article:18374401 | pubmed:language | eng | lld:pubmed |
pubmed-article:18374401 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18374401 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18374401 | pubmed:month | May | lld:pubmed |
pubmed-article:18374401 | pubmed:issn | 1095-6859 | lld:pubmed |
pubmed-article:18374401 | pubmed:author | pubmed-author:ScolesDaniel... | lld:pubmed |
pubmed-article:18374401 | pubmed:author | pubmed-author:KarlanBeth... | lld:pubmed |
pubmed-article:18374401 | pubmed:author | pubmed-author:LiAndrew JAJ | lld:pubmed |
pubmed-article:18374401 | pubmed:author | pubmed-author:ArmstrongKlar... | lld:pubmed |
pubmed-article:18374401 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18374401 | pubmed:volume | 109 | lld:pubmed |
pubmed-article:18374401 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18374401 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18374401 | pubmed:pagination | 220-5 | lld:pubmed |
pubmed-article:18374401 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:meshHeading | pubmed-meshheading:18374401... | lld:pubmed |
pubmed-article:18374401 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18374401 | pubmed:articleTitle | Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas. | lld:pubmed |
pubmed-article:18374401 | pubmed:affiliation | Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA. Andrew.Li@cshs.org | lld:pubmed |
pubmed-article:18374401 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18374401 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1956 | entrezgene:pubmed | pubmed-article:18374401 | lld:entrezgene |
entrez-gene:367 | entrezgene:pubmed | pubmed-article:18374401 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18374401 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18374401 | lld:entrezgene |
lhgdn:association:6541 | lhgdn:found_in | pubmed-article:18374401 | lld:lhgdn |
lhgdn:association:34038 | lhgdn:found_in | pubmed-article:18374401 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18374401 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18374401 | lld:pubmed |